Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.06% Nasdaq Up0.22%

More On SUNPHARMA.NS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

-NSE
625.05 Up 11.20(1.82%) 5:59AM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2013Mar 31, 2012Mar 31, 2011Mar 31, 2010
Total Revenue 112,999,000   80,195,000   57,279,000   39,040,000  
Cost of Revenue28,819,000  22,559,000  18,956,000  13,890,000  
Gross Profit 84,180,000   57,636,000   38,323,000   25,150,000  
Operating Expenses
Research Development -   -   -   -  
Selling General and Administrative -   -   -   -  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses66,427,000  50,083,000  39,621,000  28,673,000  
Operating Income or Loss 46,572,000   30,112,000   17,658,000   10,366,000  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes46,572,000  30,112,000  17,658,000  10,366,000  
Interest Expense(369,000)(282,000)(739,000) -  
Income Before Tax -   -   -   -  
Income Tax Expense8,456,000  3,132,000  1,286,000  679,000  
Minority Interest(4,863,000)(3,855,000)(913,000)41,000  
Net Income From Continuing Ops34,759,000  30,433,000  19,106,000  13,511,000  
Non-recurring Events
Discontinued Operations(65,000)(11,000)(32,000) -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 29,831,000   26,567,000   18,161,000   13,511,000  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares -   -   -   -  

Currency in INR.